Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy

Herbal active compound with immunoregulator ability is considered a potential therapy for COVID-19 oral manifestation by downregulating pro-inflammatory cytokine storm. Meanwhile, anthocyanin and ternatin are the active compounds in Clitoria ternatea, which may act as a potential immunoregulator for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexander Patera Nugraha, Desintya Rahmadhani, Martining Shoffa Puspitaningrum, Yuniar Rizqianti, Viol Dhea Kharisma, Diah Savitri Ernawati
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/81a7be990a45469aa0d42f7786197234
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:81a7be990a45469aa0d42f7786197234
record_format dspace
spelling oai:doaj.org-article:81a7be990a45469aa0d42f77861972342021-11-12T10:17:53ZMolecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy2231-40400976-209410.4103/japtr.japtr_126_21https://doaj.org/article/81a7be990a45469aa0d42f77861972342021-01-01T00:00:00Zhttp://www.japtr.org/article.asp?issn=2231-4040;year=2021;volume=12;issue=4;spage=362;epage=367;aulast=Nugrahahttps://doaj.org/toc/2231-4040https://doaj.org/toc/0976-2094Herbal active compound with immunoregulator ability is considered a potential therapy for COVID-19 oral manifestation by downregulating pro-inflammatory cytokine storm. Meanwhile, anthocyanin and ternatin are the active compounds in Clitoria ternatea, which may act as a potential immunoregulator for COVID-19 therapy. The intention of this investigation was to investigate anthocyanin and ternatin as active compounds in C. ternatea that may be able to increase anti-inflammatory cytokine and inhibit pro-inflammatory cytokine and key proteins of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This study implemented bioinformatic approach to analyze anthocyanin and ternatin as active compounds in C. ternatea with anti- and pro-inflammatory cytokines and antiviral examination history through blind molecular docking study (in silico). Moreover, anthocyanins and ternatin were obtained from PubChem database by minimizing ligand structure in PyRx software to increase the flexibility. RCSB database was employed for preparing the protein samples consisting of interleukin (IL)-6, SARS-CoV-2-ACE2 glycoprotein complex, tumor necrosis factor-α receptor (TNF-αR), matrix metalloproteinase-9 (MMP-9), IL-6, IL-10, and human beta defensin-2 (HBD-2). In addition, The PyMol sofware was used to sterilize the protein samples to obtain the molecular docking optimization. This investigation found that, in the molecular docking simulation, the anthocyanin and ternatin showed producing the negative binding affinity to the ACE2 domain which interacted with RBD glycoprotein SARS-CoV-2. Anthocyanin and ternatin were then predicted to be able to influence any inhibitory activity of TNF-αR, MMP-9, and IL-6; increase IL-10; and increase HBD2 binding affinity values negatively. It can be predicted through molecular docking that anthocyanin and ternatin as the active compounds in C. ternatea contribute as a potential agent for COVID-19 oral manifestation therapy.Alexander Patera NugrahaDesintya RahmadhaniMartining Shoffa PuspitaningrumYuniar RizqiantiViol Dhea KharismaDiah Savitri ErnawatiWolters Kluwer Medknow Publicationsarticleanthocyaninsclitoria ternateacovid-19infectious diseasemedicineternatinTherapeutics. PharmacologyRM1-950Pharmacy and materia medicaRS1-441ENJournal of Advanced Pharmaceutical Technology & Research, Vol 12, Iss 4, Pp 362-367 (2021)
institution DOAJ
collection DOAJ
language EN
topic anthocyanins
clitoria ternatea
covid-19
infectious disease
medicine
ternatin
Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
spellingShingle anthocyanins
clitoria ternatea
covid-19
infectious disease
medicine
ternatin
Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
Alexander Patera Nugraha
Desintya Rahmadhani
Martining Shoffa Puspitaningrum
Yuniar Rizqianti
Viol Dhea Kharisma
Diah Savitri Ernawati
Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
description Herbal active compound with immunoregulator ability is considered a potential therapy for COVID-19 oral manifestation by downregulating pro-inflammatory cytokine storm. Meanwhile, anthocyanin and ternatin are the active compounds in Clitoria ternatea, which may act as a potential immunoregulator for COVID-19 therapy. The intention of this investigation was to investigate anthocyanin and ternatin as active compounds in C. ternatea that may be able to increase anti-inflammatory cytokine and inhibit pro-inflammatory cytokine and key proteins of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This study implemented bioinformatic approach to analyze anthocyanin and ternatin as active compounds in C. ternatea with anti- and pro-inflammatory cytokines and antiviral examination history through blind molecular docking study (in silico). Moreover, anthocyanins and ternatin were obtained from PubChem database by minimizing ligand structure in PyRx software to increase the flexibility. RCSB database was employed for preparing the protein samples consisting of interleukin (IL)-6, SARS-CoV-2-ACE2 glycoprotein complex, tumor necrosis factor-α receptor (TNF-αR), matrix metalloproteinase-9 (MMP-9), IL-6, IL-10, and human beta defensin-2 (HBD-2). In addition, The PyMol sofware was used to sterilize the protein samples to obtain the molecular docking optimization. This investigation found that, in the molecular docking simulation, the anthocyanin and ternatin showed producing the negative binding affinity to the ACE2 domain which interacted with RBD glycoprotein SARS-CoV-2. Anthocyanin and ternatin were then predicted to be able to influence any inhibitory activity of TNF-αR, MMP-9, and IL-6; increase IL-10; and increase HBD2 binding affinity values negatively. It can be predicted through molecular docking that anthocyanin and ternatin as the active compounds in C. ternatea contribute as a potential agent for COVID-19 oral manifestation therapy.
format article
author Alexander Patera Nugraha
Desintya Rahmadhani
Martining Shoffa Puspitaningrum
Yuniar Rizqianti
Viol Dhea Kharisma
Diah Savitri Ernawati
author_facet Alexander Patera Nugraha
Desintya Rahmadhani
Martining Shoffa Puspitaningrum
Yuniar Rizqianti
Viol Dhea Kharisma
Diah Savitri Ernawati
author_sort Alexander Patera Nugraha
title Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
title_short Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
title_full Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
title_fullStr Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
title_full_unstemmed Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy
title_sort molecular docking of anthocyanins and ternatin in clitoria ternatea as coronavirus disease oral manifestation therapy
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/81a7be990a45469aa0d42f7786197234
work_keys_str_mv AT alexanderpateranugraha moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
AT desintyarahmadhani moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
AT martiningshoffapuspitaningrum moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
AT yuniarrizqianti moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
AT violdheakharisma moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
AT diahsavitriernawati moleculardockingofanthocyaninsandternatininclitoriaternateaascoronavirusdiseaseoralmanifestationtherapy
_version_ 1718430999389405184